Aflibercept, via binding vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), effectively decreased macular edema by deactivating microglia and improving the drainage function of retinal Müller glia and retinal pigment epithelium. This evidence concerns the gene VEGFA and macular retinal edema.